Investors locked in profits on Marinus Pharmaceuticals Inc. (Nasdaq: MRNS). Shares of the biopharmaceutical dropped $1.44 to close at $7.89.
Profit taking weighs down Marinus Pharmaceuticals
December 15, 2017 at 18:47 PM EST
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|